Ask a doctor about a prescription for DIARFIN 2 mg HARD CAPSULES
Package Leaflet: Information for the User
Diarfin 2 mg Hard Capsules
loperamide hydrochloride
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Follow exactly the administration instructions of the medicine contained in this leaflet or as indicated by your doctor or pharmacist.
Contents of the Package Leaflet
Diarfin is an antidiarrheal that reduces intestinal movements and secretions, resulting in a decrease in liquid stools.
Diarfin is used for the symptomatic treatment of acute non-specific diarrhea in adults and children over 12 years of age.
You should consult a doctor if it worsens or does not improve after 2 days.
Do not take Diarfin
Warnings and precautions
Consult your doctor or pharmacist before starting to take Diarfin.
Children and adolescents
This medicine should not be administered to children under 12 years of age without consulting a doctor.
Other medicines and Diarfin
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicine.
In particular, inform your doctor or pharmacist if you are taking any of the following medicines:
Diarfin may enhance the effect of similar medicines.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy
The safety of this medicine during pregnancy has not been established, so pregnant women should not take this medicine unless prescribed by a doctor.
Breastfeeding
Women who are breastfeeding should not use this medicine without consulting their doctor, as small amounts of it may pass into breast milk.
Driving and using machines
Drowsiness, dizziness, or drowsiness may occur during treatment with Diarfin, so it is advised not to use machinery or drive vehicles.
Diarfin contains lactose.If your doctor has told you that you have an intolerance to some sugars, consult with him before taking this medicine.
Diarfin contains the colorant Orange Yellow S (E-110).This medicine may cause allergic reactions because it contains Orange Yellow S (E-110). It can cause asthma, especially in patients allergic to acetylsalicylic acid.
Follow exactly the administration instructions of the medicine contained in this leaflet or as indicated by your doctor or pharmacist. In case of doubt, ask your doctor or pharmacist.
The recommended dose is:
Adults
2 capsules (4 mg of loperamide hydrochloride) as an initial dose, followed by 1 capsule (2 mg of loperamide hydrochloride) after each diarrheal stool.
The maximum dose for adults is 8 capsules (16 mg of loperamide hydrochloride) per day.
Children over 12 years of age
1 capsule (2 mg of loperamide hydrochloride) as an initial dose, followed by 1 capsule (2 mg of loperamide hydrochloride) after each diarrheal stool.
In children, the maximum daily dose should be related to body weight:
Child's weight | Maximum number of capsules per day |
From 27 kg | Maximum 4 capsules |
From 34 kg | Maximum 5 capsules |
From 40 kg | Maximum 6 capsules |
From 47 kg | Maximum 7 capsules |
Patient with liver disease
They should consult their doctor before taking this medicine.
Method of administration
This medicine is taken orally. Swallow the capsules with a glass of water.
Do not exceed the recommended dose.
If you think the effect of Diarfin is too strong or too weak, tell your doctor or pharmacist.
If you take more Diarfin than you should
If you have taken too much Diarfin, contact a doctor or hospital as soon as possible for advice. The symptoms may include: increased heart rate, irregular heartbeats, cardiac arrhythmias (these symptoms can have potentially serious and life-threatening consequences), muscle stiffness, uncoordinated movements, drowsiness, difficulty urinating, or weak breathing.
Children react more severely to high amounts of Diarfin than adults. If a child takes an excessive amount or presents any of the above symptoms, call a doctor immediately.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone (91) 562 04 20, indicating the medicine and the amount taken.
If you forget to take Diarfin
Do not take a double dose to make up for the forgotten dose.
If you have any other doubts about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If any of the following side effects occur, discontinue treatment and consult your doctor:
Other side effects that may occur are:
Common side effects (may affect up to 1 in 10 people):
Uncommon side effects (may affect up to 1 in 100 people):
Rare side effects (may affect up to 1 in 1,000 people):
Side effects of unknown frequency (cannot be estimated from the available data):
Upper abdominal pain, abdominal pain radiating to the back, abdominal tenderness, fever, rapid pulse, nausea, vomiting, which may be symptoms of pancreatitis (acute pancreatitis).
Reporting of side effects
If you experience any side effects, consult your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish Medicines and Health Products Agency (AEMPS) https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
This medicine does not require special storage conditions.
Do not use this medicine after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Medicines should not be disposed of via wastewater or household waste. Dispose of the packaging and any unused medicine in the pharmacy's SIGRE collection point. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.
Composition of Diarfin
Capsule content:pregelatinized corn starch, lactose monohydrate, anhydrous colloidal silica, and magnesium stearate.
Hard capsule:gelatin, orange yellow S (E-110), and titanium dioxide (E-171).
Appearance of the product and pack contents
Diarfin is presented in the form of hard gelatin capsules with an orange cap and orange body.
It is presented in PVC-PVDC/ALU blisters. Each pack of Diarfin contains 10 or 20 capsules.
Marketing authorization holder and manufacturer
Laboratorios Cinfa, S.A.
Carretera Olaz-Chipi, 10. Polígono Industrial Areta
31620 Huarte (Navarra) – Spain
Date of the last revision of this leaflet:July 2022
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for DIARFIN 2 mg HARD CAPSULES – subject to medical assessment and local rules.